How Much Did Sampling Human Raise?
Funding & Key Investors

Sampling Human has secured $2M in total capital, with its most recent financing round bringing in $2M. This major strategic investment underscores the company's significant progress in the synthetic biology diagnostics sector.

What is Sampling Human?

Sampling Human
Business ServicesResearch & DevelopmentManufacturing

Sampling Human, Inc. is a pioneering synthetic biology diagnostics company focused on developing innovative methods for the early detection of diseases. The company has engineered accessible diagnostic reagent kits for liquid biopsies and a proprietary method for analyzing cells using living cell technology. Their "Diagnostics On Target" (DOT) platform represents a next-generation cell diagnostics technology, designed to translate extensive single-cell data into clinical practice, thereby enhancing early disease detection and treatment monitoring. Sampling Human's approach aims to elevate assay sensitivity and speed, surpassing the performance limitations of conventional instruments like flow cytometry.

How much funding has Sampling Human raised?

Sampling Human has raised a total of $2M across 1 funding round:

2022

Other Financing Round

$2M

Other Financing Round (2022): $2M with participation from Longevitytech.Fund, i&i Biotech Fund, and Formic Ventures

Key Investors in Sampling Human

Longevitytech.Fund

Longevitytech.Fund is focused on global investments in technologies that aim to extend healthy lifespans. The company seeks to support innovations that contribute to longevity and improved health outcomes.

i&i Biotech Fund

Undisclosed investor participating in the funding round.

Formic Ventures

Undisclosed investor participating in the funding round.

What's next for Sampling Human?

The recent major strategic investment in Sampling Human signals a critical phase of scaling and market expansion. This capital infusion is expected to accelerate the development and commercialization of their novel diagnostic technologies, particularly the "Diagnostics On Target" platform. The company is well-positioned to leverage this backing to solidify its market presence in early disease detection and potentially explore new therapeutic monitoring applications. Future growth will likely involve strategic partnerships and further technological advancements to address unmet needs in clinical diagnostics.

See full Sampling Human company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesHuman Resources Management Systems (HRMS)
Accounting for Legal PracticesBusiness Services
Business ServicesSoftware TestingProject Management
Business ServicesSecurity Information and Event Management (SIEM)Human Resources Management Systems (HRMS)

Frequently Asked Questions Regarding Sampling Human Financial Insights

What are the most recent funding rounds that Sampling Human has completed, and what were the funding rounds?
Sampling Human has recently completed 1 funding rounds: Other Financing Round on Apr 13, 2022.
What is the total amount of funding Sampling Human has raised to date?
Sampling Human has raised a total of $2M in funding to date.
How many funding rounds has Sampling Human completed?
Sampling Human has completed 1 funding rounds.
How much funding did Sampling Human raise in its most recent funding round?
Sampling Human raised $2M in its most recent funding round.
Who are the lead investors in Sampling Human's latest funding round?
The lead investor in Sampling Human's latest funding round was Longevitytech.Fund. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Sampling Human's history?
The largest funding round in Sampling Human's history was $2M.
See more information about Sampling Human